Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar
Released
Released
Announcement PDF
ASX Announcement
18 April 2024
Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar
Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) advises that it will release its Q3 FY24 Quarterly
Activities Report & Appendix 4C on Tuesday, 23 April 2024.
The Company will host an investor webinar via Zoom with CEO Dr Luke Reid and SVP, Therapeutics Prof. Trent Munro at
12:00pm (midday) AEST on Tuesday, 23 April 2024.
Quarterly Investor Webinar
Presenting: CEO, Dr Luke Reid and SVP, Therapeutics Prof. Trent Munro
Time: 12:00pm (midday) AEST on Tuesday, 23 April 2024
To register: Microba Q3 FY24 Investor Webinar Registration
Investor Q&As
Investors can submit questions via the Q&A functions on Zoom during the webinar. The recording will be made available on
the Company’s Investor Hub shortly after the webinar concludes at https://ir.microba.com/link/8r6X5y
Investors with complete Microba Investor Hub accounts can also submit questions prior to the webinar via Microba’s
interactive investor platform following this link: https://ir.microba.com/link/8r6X5y
This announcement has been authorised for release by the Chair and CEO.
For further information, please contact:
Dr Luke Reid
Chief Executive Officer
luke.reid@microba.com
https://ir.microba.com/welcome
About Microba Life Sciences Limited
Microba Life Sciences is a precision microbiome company driven to improve human health. With world-leading technology
for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for
major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers.
Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the
microbiome, health and disease for the development of new health solutions. For more information visit www.microba.com
.
JOIN MICROBA’S INTERACTIVE INVESTOR HUB
Visit ir.microba.com/welcome for Microba’s interactive Investor Hub
Microba Life Sciences Ltd ABN 82 617 096 652 Level 10, 324 Queen Street, Brisbane QLD 4000 Australia | 1300 974 621
Share your feedback
Discover